Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Breast cancer-specific mRNA transcripts after adjuvant chemotherapy predicts poor survival
October 5th, 2006
Breast cancer-specific mRNA transcripts after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients. In a recent article published in the Journal of Clinical Oncology, scientists in Spain studied "the prognostic significance of the presence of breast cancer-specific mRNA transcripts in peripheral blood (PB), defined by serial analysis of gene expression, in high-risk breast cancer (HRBC) patients undergoing high-dose chemotherapy after receiving adjuvant chemotherapy. "From 1994 to 2000, 84 HRBC patients (median age, 44 years; >10 nodes; 74%) received adjuvant chemotherapy (fluorouracil, epirubicin, and...
Source: Blood Weekly (2006-10-05)
|
